Literature DB >> 8314045

A bootstrap approach to estimating power for linkage heterogeneity.

S M Leal1, J Ott.   

Abstract

We examined the power of detecting linkage heterogeneity when the null hypothesis is that all families are linked to one locus (A) and the two alternative hypotheses are either 1) a proportion of the families are linked to locus A and the remaining families are linked to a second locus B or 2) a proportion of the families are linked to locus A or B and a third proportion of the families are unlinked to either locus. The power of detecting linkage heterogeneity is estimated for various proportions of families linked to loci A, B or unlinked to either locus (sampling under the alternative hypothesis). To estimate the significance level, the data set is sampled under the null hypothesis. For sampling under both hypotheses, a bootstrap approach is employed, sampling the simulated pedigrees with replacement. The power to detect linkage heterogeneity is strongest when the recombination fraction is 0 and equal proportions of the families are linked to loci A and B. The power decreases as the recombination fraction increases, the proportion of unlinked families increases and the disparity between the proportion of the families linked to either locus A or B increases. In the data set of 32 Duke Familial Alzheimer Disease families, when equal proportions of families are linked to loci A and B, the power to detect linkage heterogeneity is 0.94 using a likelihood ratio criterion of 10:1. The p value that corresponds to the likelihood ratio of 10:1 is estimated as 0.013 with a 95% confidence interval for p ranging from 0.012 to 0.014.

Entities:  

Mesh:

Year:  1993        PMID: 8314045      PMCID: PMC6141017          DOI: 10.1002/gepi.1370100623

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  8 in total

1.  Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.

Authors:  M A Pericak-Vance; J L Bebout; P C Gaskell; L H Yamaoka; W Y Hung; M J Alberts; A P Walker; R J Bartlett; C A Haynes; K A Welsh
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

2.  A multisample bootstrap approach to the estimation of maximized-over-models lod score distributions.

Authors:  J D Terwilliger; J Ott
Journal:  Cytogenet Cell Genet       Date:  1992

3.  Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17.

Authors:  J M Vance; G A Nicholson; L H Yamaoka; J Stajich; C S Stewart; M C Speer; W Y Hung; A D Roses; D Barker; M A Pericak-Vance
Journal:  Exp Neurol       Date:  1989-05       Impact factor: 5.330

4.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

5.  Evidence that the gene for tuberous sclerosis is on chromosome 9.

Authors:  A E Fryer; A Chalmers; J M Connor; I Fraser; S Povey; A D Yates; J R Yates; J P Osborne
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

6.  Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease.

Authors:  R S Kandt; J L Haines; M Smith; H Northrup; R J Gardner; M P Short; K Dumars; E S Roach; S Steingold; S Wall
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

7.  Genetic linkage evidence for heterogeneity in Charcot-Marie-Tooth neuropathy (HMSN type I).

Authors:  T D Bird; J Ott; E R Giblett; P F Chance; S M Sumi; G H Kraft
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

8.  Detecting linkage for genetically heterogeneous diseases and detecting heterogeneity with linkage data.

Authors:  L L Cavalli-Sforza; M C King
Journal:  Am J Hum Genet       Date:  1986-05       Impact factor: 11.025

  8 in total
  1 in total

1.  Searching for epistasis and linkage heterogeneity by correlations of pedigree-specific linkage scores.

Authors:  Daniel J Schaid; Shannon K McDonnell; Erin E Carlson; Stephen N Thibodeau; Janet L Stanford; Elaine A Ostrander
Journal:  Genet Epidemiol       Date:  2008-07       Impact factor: 2.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.